HAUMANN BRETT K 4
4 · Theravance Biopharma, Inc. · Filed Aug 22, 2019
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2019-08-20$21.51/sh−2,710$58,292→ 233,968 total
4 · Theravance Biopharma, Inc. · Filed Aug 22, 2019
Ordinary Shares